These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 28189533)
1. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology. Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533 [TBL] [Abstract][Full Text] [Related]
2. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer. Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624 [TBL] [Abstract][Full Text] [Related]
3. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. Bahrami A; Khazaei M; Bagherieh F; Ghayour-Mobarhan M; Maftouh M; Hassanian SM; Avan A J Cell Physiol; 2017 Nov; 232(11):2931-2937. PubMed ID: 28083912 [TBL] [Abstract][Full Text] [Related]
4. Key role of pancreatic stellate cells in pancreatic cancer. Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV Cancer Lett; 2016 Oct; 381(1):194-200. PubMed ID: 26571462 [TBL] [Abstract][Full Text] [Related]
5. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells. Nielsen MF; Mortensen MB; Detlefsen S World J Gastroenterol; 2016 Mar; 22(9):2678-700. PubMed ID: 26973408 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies. Rucki AA; Zheng L World J Gastroenterol; 2014 Mar; 20(9):2237-46. PubMed ID: 24605023 [TBL] [Abstract][Full Text] [Related]
7. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment. Li X; Ma Q; Xu Q; Duan W; Lei J; Wu E Curr Pharm Des; 2012; 18(17):2404-15. PubMed ID: 22372501 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer and its stroma: a conspiracy theory. Xu Z; Pothula SP; Wilson JS; Apte MV World J Gastroenterol; 2014 Aug; 20(32):11216-29. PubMed ID: 25170206 [TBL] [Abstract][Full Text] [Related]
9. Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes. Kadaba R; Birke H; Wang J; Hooper S; Andl CD; Di Maggio F; Soylu E; Ghallab M; Bor D; Froeling FE; Bhattacharya S; Rustgi AK; Sahai E; Chelala C; Sasieni P; Kocher HM J Pathol; 2013 May; 230(1):107-17. PubMed ID: 23359139 [TBL] [Abstract][Full Text] [Related]
11. Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells. Apte MV; Wilson JS J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():69-74. PubMed ID: 22320920 [TBL] [Abstract][Full Text] [Related]
12. Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer. Mutgan AC; Besikcioglu HE; Wang S; Friess H; Ceyhan GO; Demir IE Mol Cancer; 2018 Feb; 17(1):66. PubMed ID: 29475434 [TBL] [Abstract][Full Text] [Related]
13. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis. Thomas D; Radhakrishnan P Mol Cancer; 2019 Jan; 18(1):14. PubMed ID: 30665410 [TBL] [Abstract][Full Text] [Related]
14. Biology and clinical applications of pancreatic cancer stem cells. Abel EV; Simeone DM Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133 [TBL] [Abstract][Full Text] [Related]
15. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms. Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334 [TBL] [Abstract][Full Text] [Related]
16. [The impact of desmoplasia and pancreatic stellate cells on pancreatic cancer]. Nielsen MF; Mortensen MB; Detlefsen S Ugeskr Laeger; 2015 Aug; 177(34):. PubMed ID: 26320589 [TBL] [Abstract][Full Text] [Related]
17. The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets. Farran B; Nagaraju GP Cytokine Growth Factor Rev; 2019 Aug; 48():11-23. PubMed ID: 31331827 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation. Coleman SJ; Watt J; Arumugam P; Solaini L; Carapuca E; Ghallab M; Grose RP; Kocher HM World J Gastroenterol; 2014 Jul; 20(26):8471-81. PubMed ID: 25024603 [TBL] [Abstract][Full Text] [Related]
19. Cytokine network: new targeted therapy for pancreatic cancer. Matsuo Y; Takeyama H; Guha S Curr Pharm Des; 2012; 18(17):2416-9. PubMed ID: 22372505 [TBL] [Abstract][Full Text] [Related]
20. Breaking the stromal barrier in pancreatic cancer: Advances and challenges. Chakkera M; Foote JB; Farran B; Nagaraju GP Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189065. PubMed ID: 38160899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]